Ketamine Providers in Connecticut
17 providers across 9 cities
Connecticut has 17 ketamine therapy providers across 9 cities. The most common provider types are ketamine infusion clinic, psychiatry practice, pain management clinic. Providers in Connecticut commonly treat depression, anxiety, ptsd. Top cities include Stamford, New Haven, Danbury, Greenwich, Milford.
Ketamine Therapy in Connecticut
Connecticut offers ketamine therapy patients access to some of the most advanced clinical research programs in the world, anchored by Yale School of Medicine's Interventional Psychiatry Service. The state's HUSKY Medicaid program has covered Spravato since 2021, providing a financial pathway for eligible patients. Despite Connecticut's strong healthcare infrastructure, over half of its residents live in federally designated mental health shortage areas, making ketamine therapy's rapid-acting benefits especially valuable in underserved communities.
Connecticut ranks 16th nationally with 17 ketamine therapy providers, averaging 1.9 providers per city. The largest provider category is ketamine infusion clinic (52.9% of providers). Stamford leads the state with 4 providers.
State Regulations
Connecticut follows federal Schedule III regulations for ketamine with no state-specific ketamine clinic legislation. Practitioners must hold DEA registration for each treatment location. Connecticut's Department of Consumer Protection Drug Control Division oversees controlled substance prescribing with a robust PDMP (CPMRS) — prescribers must review PDMP records before prescribing any Schedule II-V substance for ongoing treatment.
Insurance & Medicaid Coverage
Connecticut Medicaid (HUSKY A/B/C/D) covers Spravato with prior authorization since January 1, 2021. Requirements include TRD diagnosis, age 18+, failure of at least a 4-week trial of an SSRI and one other antidepressant, and failure of one antidepressant augmentation strategy. PA requests are submitted through the CT Behavioral Health Partnership. Initial approval is up to 6 months; reauthorization requires documented improvement.
Telehealth Options
Connecticut supports telemedicine prescribing of ketamine under the DEA's extension through December 31, 2026. Connecticut additionally expanded telehealth controlled substance prescribing via state law (PA 20-2), and CT Medicaid has specific telehealth billing provisions for controlled substances.
Cost of Ketamine Therapy
IV ketamine infusions in Connecticut typically cost $250–$700 per session. Connecticut pricing varies notably. Lighthouse Wellness Center offers infusions at $250 each to expand access. Stamford-area Complete Ketamine Solutions charges $2,400 for a 6-session series. A standard initial series of 6 infusions runs $2400–$4200. Spravato (esketamine) may be partially or fully covered by insurance.
Mental Health Access
Connecticut has 24.11% of mental health needs met, requiring 74 additional practitioners (HRSA, December 2025). Over 1.87 million Connecticut residents (52% of the state population) live in federally designated mental health shortage areas — the highest proportion in New England. Connecticut has approximately 0.5 ketamine providers per 100,000 residents.
Frequently Asked Questions
- Yes. Ketamine is a Schedule III controlled substance legal for off-label use in Connecticut when prescribed by licensed providers with DEA registration. Connecticut has no additional state-specific ketamine clinic requirements. Clinics operate in Stamford, New Haven, Hartford, and surrounding communities.
- Yes. Connecticut Medicaid (HUSKY A, B, C, and D programs) has covered Spravato with prior authorization since January 1, 2021. Requirements include TRD diagnosis, failure of an SSRI and one other antidepressant, and failure of at least one augmentation strategy. Initial authorization is for up to 6 months.
- Connecticut clinics offer wide pricing variability. Lighthouse Wellness Center offers infusions at $250 each — well below the national average. Stamford-area clinics charge $400 per session ($2,400 for six). A typical 6-session series ranges from $2,400 to $4,200. Spravato may be covered with minimal copays for HUSKY-enrolled patients.